These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10853664)

  • 21. Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors.
    Xiao A; Slack TJ; Li Y; Shi D; Yu H; Li W; Liu Y; Chen X
    J Org Chem; 2018 Sep; 83(18):10798-10804. PubMed ID: 30105908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of taurolipids on Clostridium perfringens sialidase.
    Nohara-Uchida K; Kaya K
    J Biochem; 1988 May; 103(5):840-2. PubMed ID: 2903144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A tetravalent sialic acid-coated tetraphenylethene luminogen with aggregation-induced emission characteristics: design, synthesis and application for sialidase activity assay, high-throughput screening of sialidase inhibitors and diagnosis of bacterial vaginosis.
    Liu GJ; Wang B; Zhang Y; Xing GW; Yang X; Wang S
    Chem Commun (Camb); 2018 Sep; 54(76):10691-10694. PubMed ID: 30187046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uronosyl phosphonate-based sialidase inhibitor synthesis and conformational analysis.
    Bhatt B; Thomson RJ; von Itzstein M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7623-6. PubMed ID: 23122861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of N-acetylneuraminate lyase by N-acetyl-4-oxo-D-neuraminic acid.
    Gross HJ; Brossmer R
    FEBS Lett; 1988 May; 232(1):145-7. PubMed ID: 2896604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the inhibition mechanism of the sialidase activity from Newcastle disease virus.
    García Sastre A; Cobaleda C; Cabezas JA; Villar E
    Biol Chem Hoppe Seyler; 1991 Oct; 372(10):923-7. PubMed ID: 1772591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.
    Mann MC; Thomson RJ; Dyason JC; McAtamney S; von Itzstein M
    Bioorg Med Chem; 2006 Mar; 14(5):1518-37. PubMed ID: 16275104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuraminidase-resistant hemagglutination inhibitors: acrylamide copolymers containing a C-glycoside of N-acetylneuraminic acid.
    Sparks MA; Williams KW; Whitesides GM
    J Med Chem; 1993 Mar; 36(6):778-83. PubMed ID: 8459405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
    Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
    Birikaki L; Pradeau S; Armand S; Priem B; Márquez-Domínguez L; Reyes-Leyva J; Santos-López G; Samain E; Driguez H; Fort S
    Chemistry; 2015 Jul; 21(30):10903-12. PubMed ID: 26088695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat-liver-sialidase activity utilizing a tritium-labeled sialic-acid derivative of glycoprotein substrates. Activity in normal and hypothrombinemic rats.
    Bernacki RJ; Bosmann HB
    Eur J Biochem; 1973 May; 34(3):425-33. PubMed ID: 4123722
    [No Abstract]   [Full Text] [Related]  

  • 32. The Sialidases of Clostridium perfringens type D strain CN3718 differ in their properties and sensitivities to inhibitors.
    Li J; McClane BA
    Appl Environ Microbiol; 2014 Mar; 80(5):1701-9. PubMed ID: 24375134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4α position as possible inhibitors of sialidases.
    Rota P; Allevi P; Agnolin IS; Mattina R; Papini N; Anastasia M
    Org Biomol Chem; 2012 Apr; 10(14):2885-94. PubMed ID: 22395901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase chemoenzymatic synthesis of C-sialosides.
    Baytas SN; Wang Q; Karst NA; Dordick JS; Linhardt RJ
    J Org Chem; 2004 Oct; 69(20):6900-3. PubMed ID: 15387620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome.
    Kim JH; Ryu YB; Lee WS; Kim YH
    Bioorg Med Chem; 2014 Nov; 22(21):6047-52. PubMed ID: 25277281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional-group tuning in the design of neuraminidase inhibitors.
    Sabesan S; Neira S; Wasserman Z
    Carbohydr Res; 1995 Feb; 267(2):239-61. PubMed ID: 7895225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of Clostridium perfringens mutants altered in both hemagglutinin and sialidase production.
    Rood JI; Wilkinson RG
    J Bacteriol; 1975 Aug; 123(2):419-27. PubMed ID: 169224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthesis of a series of deoxygenated 2,3-difluoro-N-acteylneuraminic acid derivatives as potential sialidase inhibitors.
    Hader S; Watts AG
    Carbohydr Res; 2013 Jun; 374():23-8. PubMed ID: 23618621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards the synthesis of sialic acid-based Salmonella typhimurium sialidase inhibitors.
    Angus DI; von Itzstein M
    Carbohydr Res; 1995 Sep; 274():279-83. PubMed ID: 7585710
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
    Honda T; Yoshida S; Arai M; Masuda T; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1929-32. PubMed ID: 12113811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.